Kiin Bio raises £1.6m pre-seed led by b2venture to launch AI-driven drug discovery platform

Kiin Bio is building an AI-native drug discovery platform that integrates virtual scientists, agent-based tools and scalable infrastructure to unify fragmented research workflows from literature review through to laboratory execution.